retatrutide clinical trial thailand Triumph-1 Results for and Weight Loss | Daniel Drucker posted on the topic A new clinical trial from

For a detailed head-to-head comparison, see retatrutide vs tirzepatide

The reconstituted form requires stricter temperature control, more careful handling, and has a significantly shorter usable lifespan

Retatrutide targets three receptors Retatrutide (LY3437943) takes the concept further

Its triple-hormone mechanism, impressive clinical trial outcomes, and potential to deliver substantial weight loss have positioned it as a possible next-generation treatment for obesity and metabolic disease

It's now available in pill form for both type 2 diabetes (originally called Rybelsus, but now known as Ozempic pill) and weight loss (a Wegovy pill approved in 2025)

*Ozempic and Mounjaro are primarily approved for type 2 diabetes in many countries, while Wegovy and Zepbound are specifically approved for chronic weight management